FUNDAMENTAL ANALYSIS
PFE
Pfizer
FUNDAMENTAL RATING
FUNDAMENTAL SCORE
46 / 100
Summary
Pfizer’s reported annual history is dominated by an extreme outlier in recent years that materially distorts multi-year rates. Revenue compounded at -14.6% a year (CAGR, or compound annual growth rate) and net income compounded at -37.2% a year across three years; latest annual revenue fell 1.6% (YoY, or year-over-year) and net income fell 3.2% (YoY). The most recent quarter reported a $-248M net loss, a QoQ (quarter-over-quarter) decline of 109.2%, which runs against an improving quarterly revenue direction. Assets cover liabilities 1.71 times. The Altman Z-score of 2.13 sits in the grey zone between the distress threshold of 1.81 and the safe threshold of 2.99. The Piotroski F-Score of 4 on a 0 to 9 quality scale is a mixed earnings-quality reading, and the P/E (TTM) of 40.16 with EPS (TTM, Diluted) of $0.76 implies a rich multiple versus the market. The next earnings report must show whether quarterly net income returns to sustained positive levels and whether annual net income growth resumes.
Revenue — Annual Comparison
Net Income — Annual Comparison
Quarterly Detail Charts
Quarterly Revenue
Quarterly Net Income
Piotroski F-Score Breakdown
4/9 · Neutral
Profitability — Net income positive this fiscal year
Pass
Return on Assets — Return on Assets improved year-over-year
Fail
Cash flow positive — Cash from operations positive this fiscal year
Pass
Earnings quality — Cash from operations exceeds net income
Pass
Leverage down — Long-term debt / total assets improved
Fail
Liquidity up — Current ratio improved year-over-year
Fail
No share dilution — Share count did not increase year-over-year
Fail
Margin up — Gross margin expanded year-over-year
N/A
Asset efficiency — Asset turnover improved year-over-year
Pass
Data Source
This dashboard applies a modified 9-signal Piotroski F-Score (Piotroski, 2000) and Altman Z-Score models. Fundamental filing data is sourced from the SEC's EDGAR XBRL database (primary), with API Ninjas as backup for freshly-filed 10-Ks not yet in SEC. Live price, market cap, and EPS display use Tiingo end-of-day data. This page is informational analysis, not investment advice. See Financial Disclaimer.
Recent Filings
Formula & Methodology
Trend inputAnnual revenue and net income year-over-year direction contributes 20% of the score.
Piotroski inputModified 9-test Piotroski F-Score (Quality) contributes 40% of the score.
Altman inputAltman Z-Score (Distress) contributes 40% of the score.
Rating ruleFormula: Trend (20%) + Piotroski F-Score (40%) + Altman Z-Score (40%). Trend blends annual revenue and net income year-over-year direction. Piotroski is the modified 9-test variant (7 classic + 2 cash-flow tests). Altman uses the 1968 Z-Score with Safe/Grey/Distress zones. Combined blend uses ±0.45 thresholds: Bullish at +0.45 or higher, Bearish at -0.45 or lower, Neutral in between. Missing sub-signals count as Neutral (0) and weights are not re-normalized — a company with fewer available signals must earn its rating from stronger reads on the remaining pillars.